Cue biopharma to host business update call and webcast

Cambridge, mass., nov. 10, 2020 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted t cells within the patient's body, announced today it will host a conference call and webcast to provide a business update on tuesday, november 17, 2020 at 4:30 p.m. est. live and archived versions of the event can be accessed via the company's website.
CUE Ratings Summary
CUE Quant Ranking